Femasys (FEMY) Retained Earnings (2020 - 2026)
Femasys' (FEMY) quarterly Retained Earnings came in at -$145.0 million in Q1 2026, down 8.93% YoY from -$159.2 million in Q1 2025, and down 199.0% on a QoQ basis from $146.4 million in Q4 2025.
Femasys (FEMY) Retained Earnings (2020 - 2026) Analysis & Trends
Femasys (FEMY) has 7 years of Retained Earnings data on file, last reported at -$145.0 million in Q1 2026.
- Quarterly Retained Earnings fell 8.93% year-over-year to -$145.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$145.0 million (down 8.93% YoY) and the FY2025 annual result came in at $146.4 million, up 215.13% from the prior year.
- Retained Earnings declined to -$145.0 million in Q1 2026, from $146.4 million in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of $146.4 million in Q4 2025 to a low of -$145.0 million in Q1 2026.
- A 5-year average of $14.3 million and a median of $108.7 million in 2022 frame the typical range for Retained Earnings.
- Annual changes were most pronounced in 2022 — Retained Earnings jumped 235.27% — and 2025, when it plunged 206.48%.
- Tracing FEMY's Retained Earnings over 5 years: stood at -$94.1 million in 2022, then jumped by 231.71% to $124.0 million in 2023, then slumped by 202.59% to -$127.2 million in 2024, then surged by 215.13% to $146.4 million in 2025, then tumbled by 199.0% to -$145.0 million in 2026.
- The last three Retained Earnings figures came in at -$145.0 million (Q1 2026), $146.4 million (Q4 2025), and $139.7 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 130.04 Bn | 124.82 Bn | 1.96 Bn | 6.84 Bn |
| 2 | Becton Dickinson | 51.73 Bn | 50.87 Bn | 2.32 Bn | 17.51 Bn |
| 3 | Alcon | 35.41 Bn | 34.06 Bn | 1.68 Bn | - |
| 4 | Resmed | 33.27 Bn | 31.80 Bn | 861.22 Mn | 7.26 Bn |
| 5 | Medline | 28.23 Bn | 25.55 Bn | 2.22 Bn | 11.40 Bn |
| 6 | West Pharmaceutical Services | 24.99 Bn | 24.55 Bn | 329.20 Mn | 4.62 Bn |
| 7 | Solventum | 15.29 Bn | 14.88 Bn | 1.29 Bn | 3.92 Bn |
| 8 | Cooper Companies | 14.79 Bn | 14.66 Bn | 735.40 Mn | 7.70 Bn |
| 9 | Baxter International | 13.61 Bn | 11.46 Bn | 1.03 Bn | 13.81 Bn |
| 10 | Femasys | 9.57 Mn | 8.12 Mn | 189,391.00 | -149.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -144.98 Mn |
| Dec 31, 2025 | 146.45 Mn |
| Sep 30, 2025 | 139.72 Mn |
| Jun 30, 2025 | 137.39 Mn |
| Mar 31, 2025 | -133.10 Mn |
| Dec 31, 2024 | -127.20 Mn |
| Sep 30, 2024 | 125.47 Mn |
| Jun 30, 2024 | -116.67 Mn |
| Mar 31, 2024 | 124.99 Mn |
| Dec 31, 2023 | 123.99 Mn |
| Sep 30, 2023 | 112.88 Mn |
| Jun 30, 2023 | 110.98 Mn |
| Mar 31, 2023 | -97.08 Mn |
| Dec 31, 2022 | -94.13 Mn |
| Sep 30, 2022 | 108.73 Mn |
| Jun 30, 2022 | -88.26 Mn |
| Mar 31, 2022 | -85.62 Mn |
| Dec 31, 2021 | -82.74 Mn |
| Sep 30, 2021 | -80.38 Mn |
| Jun 30, 2021 | 108.34 Mn |